|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: LASTACAFT
Summary for Tradename: LASTACAFT
|
| |||||||||
Clinical Trials for: LASTACAFTA Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis Status: Completed Condition: Conjunctivitis, Allergic Ocular Allergy Treatment Practical Impact Trial Status: Not yet recruiting Condition: Allergic Conjunctivitis; Rhinoconjunctivitis A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis Status: Completed Condition: Conjunctivitis, Allergic A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft Status: Recruiting Condition: Allergic Conjunctivitis Safety and Efficacy Study of a Eye Drop for Eye Allergy Status: Completed Condition: Allergic Conjunctivitis Comparison of Tolerability Between Two Allergy Drops Status: Enrolling by invitation Condition: Allergic Conjunctivitis Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | LASTACAFT | alcaftadine | SOLUTION/DROPS; OPHTHALMIC | 022134 | Jul 28, 2010 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allergan | LASTACAFT | alcaftadine | SOLUTION/DROPS; OPHTHALMIC | 022134 | Jul 28, 2010 | RX | Yes | 5,468,743 | Y | Y | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc